Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer
Conditions: Gastric Cancer; Metastasis Interventions: Drug: Apatinib Mesylate; Drug: Camrelizumab Sponsor: Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials